Med Ad News announces the winners for the 2017 Manny Awards, celebrating the best in the healthcare communications industry.
Vernalis plc announces today that the US Food and Drug Administration issued a Complete Response Letter (CRL) regarding the New Drug Application for CCP-07.
The new identity emphasizes the agency’s conviction that the full potential of specialty and orphan brands can only be achieved when the needs and beliefs of patients and HCPs are equally appreciated and aligned.
Merck announced today a $300,000 cash donation to support non-governmental organization partners working to eliminate river blindness (onchocerciasis) and lymphatic filariasis (LF) in Africa.
Centron, a full-service, wholly integrated healthcare communications firm and recipient of Med Ad News Agency of the Year in 2016, announced the appointment of Meredith Pugh as Chief Growth and Strategy Officer.
Kowa Pharmaceuticals America Inc. today announced publication of results of the INTREPID Trial (HIV-infected patieNts and TREatment with PItavastatin vs. pravastatin for Dyslipidemia) in The Lancet HIV. Results of the Phase 4 trial showed that LIVALO (pitavastatin) 4 mg was superior to pravastatin 40 mg in reducing LDL cholesterol (LDL-C) in adults with HIV and dyslipidemia and had a comparable safety profile.